NHIA News | Centers for Medicare and Medicaid Services

Announcing NHIA University: Our New Online Education Platform Free for Members

February 1, 2022

Free for all members, NHIA University houses our complete library of educational content for all roles and interests within home and alternate site infusion. The categorized and searchable interface provides a personalized learning dashboard tied to your NHIA member account and includes all of our continuing education (CE) credit offerings for Pharmacists, Pharmacy Technicians, RNs & RDs.

NHIA Guidance to Address Shortages of Sterile Water and Sodium Chloride 0.9% for Injection for Compounding Sterile Preparations

January 18, 2022

NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available.

NHIA and Allied Organizations Urge FDA, State Boards of Pharmacy to Investigate, Regulate Direct Access Infusion Businesses

January 18, 2022

The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.

NHIA Issues Guidance to Address Shortages of Administration Sets for Ambulatory Infusion Pumps

December 28, 2021

Ambulatory infusion pump sets for use in the United States are in limited supply. NHIA has developed product shortage recommendations to help clinicians manage patients during this time when pump sets may not be readily available.

CMS Releases Final DEMPOS Rule, Pump Proposal Not Included

December 21, 2021

CMS issued the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) final rule and is not finalizing its interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps. 

Support for our members in Kentucky after the recent, devastating tornadoes

December 14, 2021

Please know that NHIA is here to help in whatever ways we can. If your organization is struggling to source supplies, arrange for alternative patient care, understand how emergency declarations and waivers impact your operations, or anything else, feel free to reach out to us.

NHIA Welcomes Eitan Medical to its Future of Infusion Advisory Council

November 30, 2021

With Eitan Medical’s global footprint, this strategic partnership expands the international presence within the advisory group and will inform the discussion around bringing connected technology solutions to the home and alternate site infusion industry.

NHIA’s Bill Noyes Discusses New Coverage Criteria for Parenteral & Enteral Nutrition on ASPEN’s Podcast

November 29, 2021

Learn about the new LCDs, what it means for home PEN patients and home providers and the challenges that still exist in home PEN Medicare coverage which will require advocacy from NHIA, ASPEN, home care clinicians and patients.

NHIA welcomes PlayMaker Health to the Future of Infusion Advisory Council

November 15, 2021

This strategic partnership between NHIA and PlayMaker Health will bring a unique perspective to the FIAC, adding support for data-driven programs critical to expanding access of home and alternate site infusion.

CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion

November 4, 2021

Advocacy News CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion November 4, 2021 This week, the Centers for Medicare & Medicaid Services (CMS) released a

Registration Open for NHIA’s 2022 Annual Conference in Nashville

October 27, 2021

Registration is now open for the National Home Infusion Association’s 2022 Annual Conference, to be held March 12-16, 2022, at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee.

Transitional Benefit Did Not Boost DMEPOS Utilization in 2019

October 5, 2021

New publicly available data from the Centers for Medicare and Medicaid Services for CY 2019 shows that beneficiary utilization of the Part B DMEPOS home

Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study

October 1, 2021

NHIF Research Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study September/October 2021 By Danell

NHIA Submits Comments on Proposed 2022 Physician Fee Schedule

September 14, 2021

Regulatory update NHIA Submits Comments on Proposed 2022 Physician Fee Schedule September 13, 2021 On September 10, NHIA submitted comments to the Centers for Medicare

NHIA to Publish Scholarly Journal for Infusion Therapies

September 13, 2021

This new scholarly journal will feature independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.

NHIA and 20+ Organizations Sign Joint Letter to Congress to Support Home Infusion Legislation

September 7, 2021

On September 8, a group of stakeholders, including home infusion providers, patient advocacy groups, professional societies, and industry suppliers, sent a letter to leaders in the House of Representatives and the Senate encouraging them to pass the Preserving Patient Access to Home Infusion Act (S 2652; H.R. 5067).

NHIA Comments on Medicare Home Health Proposed Rule

August 27, 2021

Regulatory update NHIA Comments on Medicare home health proposed rule August 27, 2021 NHIA has submitted comments to CMS on the CY 2022 Home Health

Announcing NHIA University: Our New Online Education Platform Free for Members

February 1, 2022

NHIA Guidance to Address Shortages of Sterile Water and Sodium Chloride 0.9% for Injection for Compounding Sterile Preparations

January 18, 2022

NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available.

NHIA and Allied Organizations Urge FDA, State Boards of Pharmacy to Investigate, Regulate Direct Access Infusion Businesses

January 18, 2022

The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.

NHIA Issues Guidance to Address Shortages of Administration Sets for Ambulatory Infusion Pumps

December 28, 2021

CMS Releases Final DEMPOS Rule, Pump Proposal Not Included

December 21, 2021

Support for our members in Kentucky after the recent, devastating tornadoes

December 14, 2021

NHIA Welcomes Eitan Medical to its Future of Infusion Advisory Council

November 30, 2021

NHIA’s Bill Noyes Discusses New Coverage Criteria for Parenteral & Enteral Nutrition on ASPEN’s Podcast

November 29, 2021

NHIA welcomes PlayMaker Health to the Future of Infusion Advisory Council

November 15, 2021

CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion

November 4, 2021

Advocacy News CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion November 4, 2021 This week, the Centers for Medicare & Medicaid Services (CMS) released a

Registration Open for NHIA’s 2022 Annual Conference in Nashville

October 27, 2021

Transitional Benefit Did Not Boost DMEPOS Utilization in 2019

October 5, 2021

New publicly available data from the Centers for Medicare and Medicaid Services for CY 2019 shows that beneficiary utilization of the Part B DMEPOS home

Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study

October 1, 2021

NHIF Research Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study September/October 2021 By Danell

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

News

In 2022, We Need Your Support

Announcing NHIA University: Our New Online Education Platform Free for Members

NHIA Guidance to Address Shortages of Sterile Water and Sodium Chloride 0.9% for Injection for Compounding Sterile Preparations

NHIA and Allied Organizations Urge FDA, State Boards of Pharmacy to Investigate, Regulate Direct Access Infusion Businesses

NHIA Issues Guidance to Address Shortages of Administration Sets for Ambulatory Infusion Pumps

CMS Releases Final DEMPOS Rule, Pump Proposal Not Included

Support for our members in Kentucky after the recent, devastating tornadoes

NHIA Welcomes Eitan Medical to its Future of Infusion Advisory Council

NHIA’s Bill Noyes Discusses New Coverage Criteria for Parenteral & Enteral Nutrition on ASPEN’s Podcast

NHIA welcomes PlayMaker Health to the Future of Infusion Advisory Council

CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion

Registration Open for NHIA’s 2022 Annual Conference in Nashville

Transitional Benefit Did Not Boost DMEPOS Utilization in 2019

Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study

NHIA Submits Comments on Proposed 2022 Physician Fee Schedule

NHIA to Publish Scholarly Journal for Infusion Therapies

NHIA and 20+ Organizations Sign Joint Letter to Congress to Support Home Infusion Legislation

NHIA Comments on Medicare Home Health Proposed Rule

Announcing NHIA University: Our New Online Education Platform Free for Members

NHIA Guidance to Address Shortages of Sterile Water and Sodium Chloride 0.9% for Injection for Compounding Sterile Preparations

NHIA and Allied Organizations Urge FDA, State Boards of Pharmacy to Investigate, Regulate Direct Access Infusion Businesses

NHIA Issues Guidance to Address Shortages of Administration Sets for Ambulatory Infusion Pumps

CMS Releases Final DEMPOS Rule, Pump Proposal Not Included

Support for our members in Kentucky after the recent, devastating tornadoes

NHIA Welcomes Eitan Medical to its Future of Infusion Advisory Council

NHIA’s Bill Noyes Discusses New Coverage Criteria for Parenteral & Enteral Nutrition on ASPEN’s Podcast

NHIA welcomes PlayMaker Health to the Future of Infusion Advisory Council

CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion

Registration Open for NHIA’s 2022 Annual Conference in Nashville

Transitional Benefit Did Not Boost DMEPOS Utilization in 2019

Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study

NHIA Submits Comments on Proposed 2022 Physician Fee Schedule

NHIA to Publish Scholarly Journal for Infusion Therapies

NHIA and 20+ Organizations Sign Joint Letter to Congress to Support Home Infusion Legislation

NHIA Comments on Medicare Home Health Proposed Rule

QUick links

About Us

Get in touch